VOLUME 12 • NUMBER 3–4 MARCH–APRIL 2015 • SUPPLEMENT A
A SUPPLEMENT TO INNOVATIONS IN CLINICAL NEUROSCIENCE
ISCTM wishes to recognize its
Sustaining Corporate Members
PLATINUM
Janssen, Pfizer
GOLD
Bracket, Roche, Shire
SILVER
AbbVie, Lilly, Otsuka, Sunovion, Takeda
BRONZE
Alkermes, AMGEN, Boehringer-Ingelheim,
Covance, Forum, INC Research, NeuroCog Trials,
Novartis, PPD, ProPhase, Thievon-Wright
Consulting
[ V O L U M E 1 2 , N U M B E R 3 – 4 , S U P P L E M E N T A , M A R C H – A P R I L 2 0 1 5 ] Innovations in CLINICAL NEUROSCIENCE
41S
BECOME A MEMBER
Not a Member Yet? Some of the member benefits
you could be receiving: discounted registration
fees, access to the full library of archived meeting
materials, and participation in ISCTM Working
Groups.
click here to JOIN TODAY
ISCTM Workgroups
ISCTM supported Working Groups provide an outlet for broader
membership participation in the ongoing work of the Society.
Below is listing of active ISCTM working groups. For detailed
information on each working group or information on joining or
forming an ISCTM working group CLICK HERE.
ADAPTIVE DESIGN
Chairs: Ron Marcus, MD, and Judith Kando, PharmD
ADDRESSING METHODOLOGICAL CHALLENGES IN INTERNATIONAL
CNS CLINICAL TRIALS
Chairs: Richard Keefe, PhD, and Amir Kalali, MD
ALGORITHMS/FLAGS TO IDENTIFY CLINICAL INCONSISTENCY IN
THE USE OF RATING SCALES IN CNS RCTs
Chairs: Jonathan Rabinowitz, MD, and Nina R. Schooler, PhD
ASSESSING ABUSE LIABILITY POTENTIAL
Chairs: Marta Sokolowska, PhD; Michael Klein, PhD;
and Beatrice Setnik, PhD
BPSD
Chairs: Larry Ereshefsky, PharmD; David Miller, MD;
and Luca Pani, MD
BIOMARKERS
Chairs: Steven Potkin, MD, and Don Goff, MD
COGNITIVE ASSESSMENT IN ALZHEIMER'S DISEASE
Chairs: Holly Posner, MD, and Philip Harvey, PhD
IDENTIFYING NON-ADHERENCE IN CNS CLINICAL TRIALS
Chairs: Thomas Shiovitz, MD, and Earle Bain, MD
IMPLEMENTING INNOVATIONS IN CNS CLINICAL TRIALS
Chairs: Gary Sachs, MD, and Michael Detke, MD, PhD
NEGATIVE SYMPTOMS
Chairs: Stephen Marder, MD, and David Daniel, MD
SUICIDAL IDEATION AND BEHAVIOR ASSESSMENT
Chairs: Larry Alphs, MD, PhD; Phillip Chappell, MD, MBA;
Michelle Stewart, PhD